|
Factors
|
Multivariate analysis
|
|---|
| |
HR (95%CI)
|
P value
|
|---|
|
Age (years)
| | |
|
< 65
|
Ref
|
–
|
|
65–74
|
0.83 (0.76, 0.90)
|
< 0.01
|
|
≥ 75
|
0.64 (0.57, 0.72)
|
< 0.01
|
|
Female
|
1.18 (1.09, 1.29)
|
< 0.01
|
|
High school or above
|
1.11 (1.02, 1.20)
|
0.01
|
|
AF duration ≥ 1 year
|
1.29 (1.18. 1.40)
|
< 0.01
|
|
EHRA score
| | |
|
I
|
Ref
|
–
|
|
II
|
1.32 (1.11, 1.58)
|
< 0.01
|
|
III
|
1.32 (1.08, 1.61)
|
< 0.01
|
|
Established CAD
|
1.19 (1.07, 1.33)
|
< 0.01
|
|
Antiarrhythmic drugs
|
1.38 (1.26, 1.50)
|
< 0.01
|
|
History of RFCA
|
0.89 (0.81, 0.99)
|
0.04
|
- AF, atrial fibrillation; CAD, coronary artery disease; RFCA, radiofrequency catheter ablation; HR, hazard ratio; 95% CI, 95% confidence interval
